- 1 in 3 US adults has metabolic syndrome3
- 84 million adults have prediabetes, but 90% don’t know it4
- 30 million adults have progressed to type 2 diabetes5
- In 2017, the total estimated cost of diagnosed diabetes was $327 billion4
The US is grappling with a metabolic disease epidemic. More than 1 in 3 adults struggle with obesity,2 which can lead to type 2 diabetes and cardiovascular disease.
The new Metabolic Risk Panel from Quest Diagnostics-Cleveland HeartLab Cardiometabolic Center of Excellence includes the following components.
The Metabolic Risk Panel allows for even earlier risk identification, offering deeper insight into the cardiometabolic status of your patients than any one test alone.
The Metabolic Risk Panel supports your conversations with patients, providing you with more information to encourage them to make some of the following lifestyle modifications.
The risk of more severe outcomes from respiratory viral infections such as COVID-19 increases with preexisting conditions, including cardiovascular disease and Type II diabetes. Review our latest COVID-19 updates.
Learn more about our Metabolic Risk Panel.